|
시장보고서
상품코드
2051024
약물 전달 장치 시장 : 투여 경로별, 용도별, 최종사용자별, 지역별Drug Delivery Device Market, By Route of Administration, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
약물 전달 장치 시장은 2026년에 2,502억 2,000만 달러로 추정되며, 2033년까지 4,633억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 9.2%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 2,502억 2,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.20% | 2033년 시장 규모 예측 : | 4,633억 2,000만 달러 |
약물 전달 장치란 체내로 의약품 화합물을 운반하기 위해 사용되는 다양한 기술을 말합니다. 효과적인 약물 전달은 활성 성분이 작용 부위에서 적절한 농도로 사용할 수 있도록 보장합니다. 이를 통해 약물의 효과와 환자의 복약 순응도를 높일 수 있습니다. 바이오 의약품 및 맞춤형 의료의 급속한 발전과 만성 질환의 유병률 증가는 첨단 약물 전달 시스템에 대한 수요를 증가시킬 수 있습니다. 안전성, 정확성, 사용 편의성 향상에 초점을 맞춘 약물 전달 장치의 끊임없는 혁신은 가까운 미래에 시장 성장을 주도할 것입니다.
시장 역학
세계 약물 전달 장치 시장의 성장은 당뇨병, 암, 심혈관 질환과 같은 만성 질환의 유병률 증가에 의해 주도되고 있습니다. 고령 인구 증가와 의료비 증가도 시장 성장을 견인하고 있습니다. 그러나 첨단 배송 시스템 개발에 따른 높은 비용은 시장 성장을 저해할 수 있습니다. 또한, 혁신적인 제품에 대한 규제 장벽도 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 신흥국 시장은 시장 관계자들에게 매력적인 기회를 제공합니다. 자가 주사 기기 및 재택치료에 대한 수요 증가는 시장 성장 기회를 가져올 수 있습니다. 휴대용 및 웨어러블 투약 시스템의 지속적인 기술 발전도 성장의 기회를 가져올 것입니다. IoT(사물인터넷)를 지원하는 스마트 기기의 도입은 시장의 주요 트렌드입니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 저해요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들이 채택하고 있는 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 약물 전달 장치 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 약물 전달 장치 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 약물 전달 장치 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 약물 전달 장치 시장 : 투여 경로별, 2021년-2033년
제5장 세계의 약물 전달 장치 시장 : 용도별, 2021년-2033년
제6장 세계의 약물 전달 장치 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 약물 전달 장치 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
LSH 26.06.16Drug Delivery Device Market is estimated to be valued at USD 250.22 Bn in 2026 and is expected to reach USD 463.32 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 250.22 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.20% | 2033 Value Projection: | USD 463.32 Bn |
Drug delivery device refers to various technologies used to transport pharmaceutical compounds in the body. Effective drug delivery ensures availability of right concentrations of active pharmaceutical ingredients at the site of action. It helps improve efficacy of drugs and patient compliance. Rapid developments in biologics, personalized medicine and increasing prevalence of chronic diseases can boost demand for advanced drug delivery systems. Constant innovations in drug delivery devices focused on enhancing safety, precision and ease-of-use can drive the market growth in the near future.
Market Dynamics
Global drug delivery device market growth is driven by rising incidence of chronic illnesses such as diabetes, cancer and cardiovascular diseases. Growing geriatric population and increasing healthcare spending also drives the market growth. However, high costs associated with development of advanced delivery systems can hamper the market growth. Regulatory hurdles for innovative products can also hamper the market growth. Emerging economies offer lucrative opportunities for market players. Escalating demand for self-administered injection devices and home healthcare can offer market growth opportunities. Continued technological advancements in portable and wearable delivery systems can also offer growth opportunities. Adoption of smart devices enabled with internet of things is a key trend in the market.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global drug delivery device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, and Nemera.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global drug delivery device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery device market.
Market Segmentation
- By Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Transdermal
- Ocular
- Pulmonary
- By Application Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System Disorders
- By End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Diagnostic Centers
- Ambulatory Surgery Centers/Clinics
- Home Care Settings
- Others
- By Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Adherium Ltd.
- Amiko Digital Health Limited
- Becton, Dickinson and Company
- BIOCORP
- CeQur Corporation
- Cognita Labs
- E3D Elcam Drug Delivery Devices
- H&T Presspart Manufacturing Ltd.
- HCmed Innovations Co., Ltd.
- Medtronic plc
- Novo Nordisk A/S
- Phillips-Medisize
- Sonceboz
- Enable Injections, Inc.
- NOVO Engineering
- Elcam Medical
- Battelle
- Gerresheimer AG
- Aphios
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Drug Delivery Device Market, By Route of Administration
- Global Drug Delivery Device Market, By Application
- Global Drug Delivery Device Market, By End User
- Global Drug Delivery Device Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Drug Delivery Device Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ocular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pulmonary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Drug Delivery Device Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Respiratory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Central Nervous System Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Drug Delivery Device Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgery Centers/Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Drug Delivery Device Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2021 - 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Adherium Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amiko Digital Health Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BIOCORP
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CeQur Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cognita Labs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- E3D Elcam Drug Delivery Devices
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- H&T Presspart Manufacturing Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HCmed Innovations Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Phillips-Medisize
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sonceboz
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Enable Injections, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NOVO Engineering
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elcam Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Battelle
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gerresheimer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aphios
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
